Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes

  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Gradogna, Antonella
  • Laparra-Cuervo, Lara
  • Solsona, Carles
  • Fernández-Dueñas, Víctor|||0000-0001-7834-2965
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
  • Ciruela, Francisco|||0000-0003-0832-3739
  • Lakadamyali, Melike
  • Estévez, Raúl|||0000-0003-1579-650X
Volume-regulated anion channels (VRACs) play an important role in controlling cell volume by opening upon cell swelling. Recent work has shown that heteromers of LRRC8A with other LRRC8 members (B, C, D, and E) form the VRAC. Here, we used Xenopus oocytes as a simple system to study LRRC8 proteins. We discovered that adding fluorescent proteins to the C-terminus resulted in constitutive anion channel activity. Using these constructs, we reproduced previous findings indicating that LRRC8 heteromers mediate anion and osmolyte flux with subunit-dependent kinetics and selectivity. Additionally, we found that LRRC8 heteromers mediate glutamate and ATP flux and that the inhibitor carbenoxolone acts from the extracellular side, binding to probably more than one site. Our results also suggest that the stoichiometry of LRRC8 heteromers is variable, with a number of subunits ≥6, and that the heteromer composition depends on the relative expression of different subunits. The system described here enables easy structure-function analysis of LRRC8 proteins.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

GlialCAM/MLC1 modulates LRRC8/VRAC currents in an indirect manner, Implications for megalencephalic leukoencephalopathy

  • Elorza-Vidal, Xabier
  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Pérez-Rius, Carla
  • Alonso-Gardón, Marta
  • Armand-Ugón, Mercedes|||0000-0002-4069-9915
  • Lanciottic, Angela
  • Stefani Brignonec, Maria
  • Prat, Esther|||0000-0001-5044-4468
  • Nunes Martínez, Virginia|||0000-0002-5747-9310
  • Ambrosini, Elena
  • Gasull, Xavier|||0000-0002-6154-8323
  • Estévez, Raúl|||0000-0003-1579-650X
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy caused by mutations in either MLC1 or GLIALCAM genes. Previous work indicated that chloride currents mediated by the volume-regulated anion channel (VRAC) and ClC-2 channels were affected in astrocytes deficient in either Mlc1 or Glialcam. ClC-2 forms a ternary complex with GlialCAM and MLC1. LRRC8 proteins have been identified recently as the molecular components of VRAC, but the relationship between MLC and LRRC8 proteins is unknown. Here, we first demonstrate that LRRC8 and MLC1 are functionally linked, as MLC1 cannot potentiate VRAC currents when LRRC8A, the main subunit of VRAC, is knocked down. We determine that LRRC8A and MLC1 do not co-localize or interact and, in Xenopus oocytes, MLC1 does not potentiate LRRC8-mediated VRAC currents, indicating that VRAC modulation in astrocytes by MLC1 may be indirect. Investigating the mechanism of modulation, we find that a lack of MLC1 does not influence either mRNA or total and plasma membrane protein levels of LRRC8A; and neither does it affect LRRC8A subcellular localization. In agreement with recent results that indicated that overexpression of MLC1 decreases the phosphorylation of extracellular signal-regulated kinases (ERK), we find that astrocytes lacking MLC1 show an increase in ERK phosphorylation. In astrocytes with reduced or increased levels of MLC1 we observe changes in the phosphorylation state of the VRAC subunit LRRC8C. Our results thus reinforce previous suggestions that indicated that GlialCAM/MLC1 might modify signal transduction pathways that influence the activity of different proteins, such as VRAC.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Role of zebrafish ClC-K/barttin channels in apical kidney chloride reabsorption

  • Pérez-Rius, Carla
  • Castellanos, Aida
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Navarro, Almudena
  • Artuch, R.|||0000-0002-3422-9685
  • Estévez, Raúl|||0000-0003-1579-650X
Key points: We have characterized the zebrafish clc-k and barttin proteins, demonstrating that they form a protein complex mediating chloride flux in a similar manner to their mammalian counterparts. As in mammals, in zebrafish, clc-k and barttin are basically expressed in the kidney. Contrary to what is found in mammals, in zebrafish both proteins show an apical localization in the kidney. We have generated the first knockout in zebrafish of a CLC protein. Lack of clc-k in zebrafish resulted in embryonic lethality, possibly caused by a reduction in total chloride content. As a consequence, there is an up-regulation of other chloride channels and other regulatory mechanisms such as renin or the uro-guanylin receptor in the kidney. barttin is mislocalized in vivo when clc-k is not present, indicating that there is a mutual dependence of the protein expression and localization between barttin and clc-k proteins. Abstract: ClC-K/barttin channels are very important for salt transport in the kidney. This function can be clearly seen since mutations in CLCNKB or BSND cause Bartter's syndrome types III and IV, respectively. Working with the freshwater teleost zebrafish, we characterized the genes homologous to the mammalian chloride channel ClC-K and its obligate subunit barttin and we obtained and studied clc-k knockout zebrafish. The zebrafish clc-k/barttin proteins are very similar to their mammalian counterparts, and both proteins are necessary to mediate chloride currents. Localization studies indicated that both proteins are exclusively expressed in the apical membranes of zebrafish kidney tubules. Knockout of clc-k resulted in embryonic lethality. These animals showed barttin mislocalization and a reduction in whole-body chloride concentration, as well as up-regulation of the expression of other chloride channels and renin, and an increase in the kidney expression of the uroguanylin receptor. Our results indicate that apical kidney chloride reabsorption through clc-k/barttin channels is crucial for chloride homeostasis in zebrafish as it is in humans. The zebrafish model could be used as a new in vivo system to study ClC-K function.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Megalencephalic leukoencephalopathy with subcortical cysts, A personal biochemical retrospective

  • Estévez, Raúl|||0000-0003-1579-650X
  • Elorza-Vidal, Xabier
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Pérez-Rius, Carla
  • Armand-Ugón, Mercedes|||0000-0002-4069-9915
  • Alonso-Gardón, Marta
  • Xicoy Espaulella, Efren
  • Sirisi Dolcet, Sonia|||0000-0002-5366-7832
  • Arnedo, Tanit
  • Capdevila-Nortes, Xavier
  • López-Hernández, Tania
  • Montolio, Marisol|||0000-0001-5494-5737
  • Duarri, Anna|||0000-0003-4075-5478
  • Teijido, Oscar|||0000-0002-4600-6972
  • Barrallo Gimeno, Alejandro|||0000-0003-2086-8926
  • Palacín Prieto, Manuel|||0000-0002-8670-293X
  • Nunes Martínez, Virginia|||0000-0002-5747-9310
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by dysfunction of the role of glial cells in controlling brain fluid and ion homeostasis. Patients affected by MLC present macrocephaly, cysts and white matter vacuolation, which lead to motor and cognitive impairments. To date, there is no treatment for MLC, only supportive care. MLC is caused by mutations in the MLC1 and GLIALCAM genes. MLC1 is a membrane protein with low identity to the Kv1.1 potassium channel and GlialCAM belongs to an adhesion molecule family. Both proteins form a complex with an as-yet-unknown function that is expressed mainly in the astrocytes surrounding the blood-brain barrier and in Bergmann glia. GlialCAM also acts as an auxiliary subunit of the chloride channel ClC-2, thus regulating its localization at cell-cell junctions and modifying its functional properties by affecting the common gate of ClC-2. Recent studies in Mlc1-, GlialCAM- and Clcn2-knockout mice or Mlc1-knockout zebrafish have provided fresh insight into the pathophysiology of MLC and further details about the molecular interactions between these three proteins. Additional studies have shown that GlialCAM/MLC1 also regulates other ion channels (TRPV4, VRAC) or transporters (Na+/K+-ATPase) in a not-understood manner. Furthermore, it has been shown that GlialCAM/MLC1 may influence signal transduction mechanisms, thereby affecting other proteins not related with transport such as the EGF receptor. Here, we offer a personal biochemical retrospective of the work that has been performed to gain knowledge of the pathophysiology of MLC, and we discuss future strategies that may be used to identify therapeutic solutions for MLC patients.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Leukoencephalopathy-causing CLCN2 mutations are associated with impaired Cl- channel function and trafficking

  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Apaja, Pirjo M
  • Arnedo, Tanit
  • Castellanos, Aida
  • Elorza-Vidal, Xabier
  • Soto, David
  • Gasull, Xavier|||0000-0002-6154-8323
  • Lukacs, Gergely L
  • Estévez, Raúl|||0000-0003-1579-650X
Key points: Characterisation of most mutations found in CLCN2 in patients with CC2L leukodystrophy show that they cause a reduction in function of the chloride channel ClC-2. GlialCAM, a regulatory subunit of ClC-2 in glial cells and involved in the leukodystrophy megalencephalic leukoencephalopathy with subcortical cysts (MLC), increases the activity of a ClC-2 mutant by affecting ClC-2 gating and by stabilising the mutant at the plasma membrane. The stabilisation of ClC-2 at the plasma membrane by GlialCAM depends on its localisation at cell-cell junctions. The membrane protein MLC1, which is defective in MLC, also contributes to the stabilisation of ClC-2 at the plasma membrane, providing further support for the view that GlialCAM, MLC1 and ClC-2 form a protein complex in glial cells. Abstract: Mutations in CLCN2 have been recently identified in patients suffering from a type of leukoencephalopathy involving intramyelinic oedema. Here, we characterised most of these mutations that reduce the function of the chloride channel ClC-2 and impair its plasma membrane (PM) expression. Detailed biochemical and electrophysiological analyses of the Ala500Val mutation revealed that defective gating and increased cellular and PM turnover contributed to defective A500V-ClC-2 functional expression. Co-expression of the adhesion molecule GlialCAM, which forms a tertiary complex with ClC-2 and megalencephalic leukoencephalopathy with subcortical cysts 1 (MLC1), rescued the functional expression of the mutant by modifying its gating properties. GlialCAM also restored the PM levels of the channel by impeding its turnover at the PM. This rescue required ClC-2 localisation to cell-cell junctions, since a GlialCAM mutant with compromised junctional localisation failed to rescue the impaired stability of mutant ClC-2 at the PM. Wild-type, but not mutant, ClC-2 was also stabilised by MLC1 overexpression. We suggest that leukodystrophy-causing CLCN2 mutations reduce the functional expression of ClC-2, which is partly counteracted by GlialCAM/MLC1-mediated increase in the gating and stability of the channel.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cisplatin activates volume sensitive LRRC8 channel mediated currents in Xenopus oocytes

  • Gradogna, Antonella
  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Boccaccioa, Anna
  • Estévez, Raúl|||0000-0003-1579-650X
LRRC8 proteins have been shown to underlie the ubiquitous volume regulated anion channel (VRAC). VRAC channels are composed of the LRRC8A subunit and at least one among the LRRC8B-E subunits. In addition to their role in volume regulation, LRRC8 proteins have been implicated in the uptake of chemotherapeutic agents. We had found that LRRC8 channels can be conveniently expressed in Xenopus oocytes, a system without endogenous VRAC activity. The fusion with fluorescent proteins yielded constitutive activity for A/C, A/D and A/E heteromers. Here we tested the effect of the anticancer drug cisplatin on LRRC8A-VFP/8E-mCherry and LRRC8A-VFP/8D-mCherry co-expressing oocytes. Incubation with cisplatin dramatically activated currents for both subunit combinations, confirming that VRAC channels provide an uptake pathway for cisplatin and that intracellular cisplatin accumulation strongly activates the channels. Thus, specific activators of LRRC8 proteins might be useful tools to counteract chemotherapeutic drug resistance.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

CLCN1 Myotonia congenita mutation with a variable pattern of inheritance suggests a novel mechanism of dominant myotonia

  • Gaitan Peñas, Hector|||0000-0001-9797-903X
  • Armand-Ugón, Mercedes|||0000-0002-4069-9915
  • Macaya Ruiz, Alfons|||0000-0001-7998-4185
Introduction: Mutations in CLCN1 cause recessive or dominant forms of myotonia congenita (MC). Some mutations have been found to exhibit both patterns of inheritance but the mechanism explaining this behavior is unknown. Methods: A known recessive missense mutation, A493E, was identified in a family with dominant MC. The mutant p.A493E alone or in co-expression with wild-type (WT) ClC-1 was expressed in Xenopus oocytes. Currents were measured and biochemical assays were performed. Results: The mutant showed no significant activity and reduced total and plasma membrane (PM) protein levels. Co-expression with the mutant reduced the activity and PM levels of an engineered lower expression variant of ClC-1, whereas no effect was observed on a higher expression variant. Discussion: Our results suggest that the dominant effect of some CLCN1 mutations showing recessive or dominant inheritance patterns may be due to a dose-dependent defect in PM delivery of the WT channel. Muscle Nerve 58: 157-160, 2018.
Academica-e. Repositorio Institucional de la Universidad Pública de Navarra
Publicación Artículo científico (JournalArticle)

Megalencephalic leukoencephalopathy with subcortical cysts: a personal biochemical retrospective

  • Estévez, Raúl
  • Elorza-Vidal, Xabier
  • Gaitán-Peñas, Héctor
  • Pérez-Rius, Carla
  • Armand-Ugón, Mercedes
  • Alonso-Gardón, Marta
  • Xicoy-Espaulella, Efren
  • Sirisi, Sònia
  • Arnedo, Tanit
  • Capdevila-Nortes, Xavier
  • López-Hernández, Tania
  • Montolio, Marisol
  • Duarri, Anna
  • Teijido Hermida, Óscar
  • Barrallo-Gimeno, Alejandro
  • Palacín, Manuel
  • Nunes, Virginia
Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare type of leukodystrophy characterized by dysfunction of the role of glial cells in controlling brain fluid and ion homeostasis. Patients affected by MLC present macrocephaly, cysts and white matter vacuolation, which lead to motor and cognitive impairments. To date, there is no treatment for MLC, only supportive care. MLC is caused by mutations in the MLC1 and GLIALCAM genes. MLC1 is a membrane protein with low identity to the Kv1.1 potassium channel and GlialCAM belongs to an adhesion molecule family. Both proteins form a complex with an as-yet-unknown function that is expressed mainly in the astrocytes surrounding the blood-brain barrier and in Bergmann glia. GlialCAM also acts as an auxiliary subunit of the chloride channel ClC-2, thus regulating its localization at cell-cell junctions and modifying its functional properties by affecting the common gate of ClC-2. Recent studies in Mlc1-, GlialCAM- and Clcn2-knockout mice or Mlc1-knockout zebrafish have provided fresh insight into the pathophysiology of MLC and further details about the molecular interactions between these three proteins. Additional studies have shown that GlialCAM/MLC1 also regulates other ion channels (TRPV4, VRAC) or transporters (Na+/K+-ATPase) in a not-understood manner. Furthermore, it has been shown that GlialCAM/ MLC1 may influence signal transduction mechanisms, thereby affecting other proteins not related with transport such as the EGF receptor. Here, we offer a personal biochemical retrospective of the work that has been performed to gain knowledge of the pathophysiology of MLC, and we discuss future strategies that may be used to identify therapeutic solutions for MLC patients., This work was supported in part by grants from the European Leukodystrophies Association (ELA) Research Foundation (ELA2012- 014C2B) to RE and VN, Ministerio de Ciencia e Innovación (SAF2012-31486 to RE and SAF2015-70377 to RE and ABG), Generalitat de Catalunya ((SGR2014-1178) to RE), (SGR2014-541) to VN)), Instituto de Salud Carlos III (bodies linked to MICINN and FEDER): (ERARE) to RE, FIS PI13/00121 to VN.